FDA approves app-based remote monitoring system for patients with implantable pacemakers

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon
 - mobile

On Nov. 17, the FDA approved the MyCareLink Smart Monitor, the first app-based remote monitoring system in the U.S. for patients with implantable pacemakers.

Medtronic manufactures the system, which is compatible with the company’s pacemakers. The system includes a handheld portable device reader that is prescribed by a physician and a mobile app that is available for free on Android and Apple platforms.

With the system, patients use their smartphone or tablet to securely transmit data from their pacemakers to their physicians, confirm the date of their most recent transmission, manage pacemaker information and data transmissions and receive email or text reminders, confirmations and notifications of their data transmissions.